Trumenba 60 ug/.5mL
meningococcal group B vaccine · INJECTION, SUSPENSION · Wyeth Pharmaceutical Division of Wyeth Holdings LLC
Trumenba is a injection, suspension containing meningococcal group b vaccine at 60 ug/.5mL, taken intramuscular. Manufactured by Wyeth Pharmaceutical Division of Wyeth Holdings LLC.
Key Facts
- Brand Name
- Trumenba
- Generic Name
- meningococcal group B vaccine
- NDC Code (Product)
0005-0100- Manufacturer
- Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- Strength
- 60 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125549
- Marketing Start
- 11/05/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Trumenba used for?
Trumenba contains meningococcal group B vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is Trumenba a controlled substance?
Trumenba is not classified as a controlled substance by the DEA.
What is the generic name for Trumenba?
The generic name for Trumenba is meningococcal group B vaccine. There are no other listed brand versions of meningococcal group B vaccine.
What is the NDC code for Trumenba 60 ug/.5mL?
The NDC (National Drug Code) for Trumenba 60 ug/.5mL is 0005-0100, listed by Wyeth Pharmaceutical Division of Wyeth Holdings LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)